Annual Federal Funding Recommendations

Biomedical and Related Life Sciences Research, FY 2022


Remarkable progress in the biological and biomedical sciences is enabled by federal investments in investigator-initiated basic research across a range of fields. Continued improvements in health, new treatments for life-threatening diseases, and enhanced quality of life all require robust, predictable, and sustained budget increases for science funding agencies.

These are FASEB’s fiscal year (FY) 2022 funding recommendations for these federal agencies: